Gregory Anthony Yanik MD

Pediatric Hematology & Oncology•Ann Arbor, MI

Professor, Pediatrics & Communicable Diseases, University of Michigan Medical School

Join to View Full Profile

1540 E Hospital DrAnn Arbor, MI 48109
Phone+1 734-936-9814
Fax+1 734-232-7580

Education & Training

Cincinnati Children's Hospital Medical CenterFellowship, Pediatric Hematology/Oncology, 1988 - 1991
Corewell Health East Beaumont (Royal Oak)Residency, Internal Medicine, 1984 - 1987
Corewell Health East Beaumont (Royal Oak)Internship, Transitional Year, 1983 - 1984
Wayne State University School of MedicineClass of 1983

Certifications & Licensure

MI State Medical License 1984 - 2026
OH State Medical License 1988 - 1992
American Board of Pediatrics Pediatric Hematology-Oncology

Awards, Honors, & Recognition

Regional Top Doctor Castle Connolly, 2014
CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013

Clinical Trials

N2000-01: Double Infusion of Iodine I 131 Metaiodobenzylguanidine Followed by Autologous Stem Cell Transplantation Start of enrollment: 2004 Mar 01
Completed
Phase 1
Study of Enbrel (Etanercept) for the Treatment Sub-Acute Pulmonary Dysfunction After Allogeneic Stem Cell Transplant Start of enrollment: 2003 Oct 01
Completed
Phase 2
N2001-02: I-MIBG With Intensive Chemotherapy and Autologous Stem Cell Rescue for High-Risk Neuroblastoma Start of enrollment: 2005 Sep 01
Completed
Phase 2
Etanercept in Treating Young Patients With Idiopathic Pneumonia Syndrome After Undergoing a Donor Stem Cell Transplant Start of enrollment: 2006 Apr 01
Completed
Phase 2
Effectiveness of Etanercept for Idiopathic Pneumonia Syndrome Following Stem Cell Transplantation (BMT CTN 0403) Start of enrollment: 2007 Aug 01
Completed
Phase 3
Blood Stem Cell Transplantation for the Treatment of Older Patients With Acute Myelogenous Leukemia Start of enrollment: 2007 Mar 01
Completed
Phase 2
N2007-02:Bevacizumab,Cyclophosphamide,& Zoledronic Acid in Patients W/ Recurrent or Refractory High-Risk Neuroblastoma Start of enrollment: 2009 Dec 01
Completed
Phase 1
N2007-03: Vorinostat and 131-I MIBG in Treating Patients With Resistant or Relapsed Neuroblastoma Start of enrollment: 2010 Mar 01
Completed
Phase 1
Lenalidomide and Dinutuximab With or Without Isotretinoin in Treating Younger Patients With Refractory or Recurrent Neuroblastoma Start of enrollment: 2013 Feb 04
ACTIVE_NOT_RECRUITING
PHASE1
N2012-01: Phase 1 Study of Difluoromethylornithine (DFMO) and Celecoxib With Cyclophosphamide/Topotecan Start of enrollment: 2014 Jan 16
COMPLETED
PHASE1
131I-MIBG Alone VS. 131I-MIBG With Vincristine and Irinotecan VS131I-MIBG With Vorinostat Start of enrollment: 2014 Jul 01
Completed
Phase 2
Defibrotide Therapy for SARS-CoV2 (COVID-19) Acute Respiratory Distress Syndrome (ARDS) Start of enrollment: 2020 Oct 01
Completed
Phase 1
Join now to see all

Publications & Presentations

PubMed

Restrictive Ventilatory Defects Following Hematopoietic Stem Cell Transplant Are Associated With Increased Mortality.
Mansour Alkhunaizi, Felipe Soto-Lanza, Cheuk Hong Leung, Neel Bhan, Lara Bashoura
Transplantation and Cellular Therapy. 2025-04-01
Pediatric Acute Lymphoblastic Leukemia, Version 2.2025, NCCN Clinical Practice Guidelines In Oncology.
Hiroto Inaba, David Teachey, Colleen Annesley, Sandeep Batra, Jill Beck
Journal of the National Comprehensive Cancer Network. 2025-02-01
The Adverse Event Landscape of Stem Cell Transplant: Evidence for AGVHD Driving Early Transplant Associated Toxicities.
Takuto Takahashi, Benjamin Watkins, Brandi Bratrude, Donna Neuberg, Kyle Hebert
Transplantation and Cellular Therapy. 2025-02-01

Journal Articles

Related Peripheral Blood Stem Cell Donors Experience More Severe Symptoms and Less Complete Recovery at 1-Year Compared to Unrelated Donors
Parameswaran N Hari, David A Jacobsohn, Joseph P McGuirk, Mary M Horowitz, Walter Longo, Thomas Spitzer, Daniel J Weisdorf, Shahram Mori, David C Delgado, Marcie L Ric..., Haematologica
Veno-Occlusive Disease After High-Dose Busulfan–Melphalan in Neuroblastoma
Gregory Yanik, Morris Kletzel, Stephan Grupp, David Jacobsohn, Christopher C Dvorak, Alix E Seif, Mark Ranalli, Haydar Frangoul, Nature

Abstracts/Posters

Tisagenlecleucel Chimeric Antigen Receptor (CAR) T-Cell Therapy for Relapsed/Refractory Children and Young Adults with Acute Lymphoblastic Leukemia (ALL): Real World E...
Gregory Yanik, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019

Lectures

Molecular Detection of Minimal Residual Disease Precedes Morphological Relapse and Could be Used to Identify Relapse in Pediatric and Young Adult B-Cell Acute Lymphobl...
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Press Mentions

New Cellular Therapy Trials for Brain TumorsMarch 14th, 2025
H. Pylori May Hinder Efficacy of Immune Checkpoint InhibitorsAugust 4th, 2021
U-M Rogel Cancer Center First in Michigan to Offer All FDA Approved Car T-cell TherapiesMay 23rd, 2018
Join now to see all

Grant Support

Parametric Response Mapping (PRM) for the detection of chronic lung injury in hematopoietic cell transplant recipientsUNIVERSITY OF MICHIGAN AT ANN ARBOR2022–2026
MIBG W/ Intensive Chemotheryapy &Autologous Stem Cell Rescue For NeuroblastemaNational Center For Research Resources2007
Etanercept For Treatment Of Sub-Acute Pulm Dysfunction After Allogeneic BMTNational Center For Research Resources2007
(MIBG) With Intensive Chemotheryapy And Autologous Stem Cell Rescue For NeuroblaNational Center For Research Resources2006
131-I-Metaiodobenzylguanidine (131i-Mibg) Therapy For Refractory NeuroblastomaNational Center For Research Resources2004–2006
131-1 MIBG In Combination With Chemotherapy For NeuroblastomaNational Center For Research Resources2000–2002